Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Angiotensin II type 1a (AT-1a) receptor | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0088 | 0.1067 | 0.0717 |
Mycobacterium ulcerans | peptide deformylase | 0.0232 | 0.5725 | 1 |
Brugia malayi | Matrixin family protein | 0.0148 | 0.3006 | 1 |
Plasmodium falciparum | peptide deformylase | 0.0232 | 0.5725 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1117 | 0.3307 |
Chlamydia trachomatis | peptide deformylase | 0.0232 | 0.5725 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.1016 | 0.5314 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0132 | 0.2495 | 0.1926 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0232 | 0.5725 | 1 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0232 | 0.5725 | 1 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0075 | 0.0618 | 0.1537 |
Trypanosoma cruzi | glutathionylspermidine synthase, putative | 0.0353 | 0.9684 | 1 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0223 | 0.543 | 0.5084 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0088 | 0.1067 | 1 |
Mycobacterium ulcerans | hydrolase | 0.0075 | 0.0618 | 0.1079 |
Onchocerca volvulus | Matrilysin homolog | 0.0136 | 0.2608 | 1 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0088 | 0.1067 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0148 | 0.3006 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0232 | 0.5725 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0136 | 0.2608 | 0.859 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0087 | 0.1012 | 0.5292 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0088 | 0.1067 | 0.0717 |
Plasmodium vivax | peptide deformylase, putative | 0.0232 | 0.5725 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0109 | 0.1749 | 1 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0088 | 0.1067 | 0.0717 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0223 | 0.543 | 0.5084 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0109 | 0.1749 | 1 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0232 | 0.5725 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0088 | 0.1067 | 0.0717 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0088 | 0.1067 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.26 | 0.8561 |
Onchocerca volvulus | 0.0087 | 0.1016 | 0.3431 | |
Echinococcus multilocularis | expressed protein | 0.0363 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.2209 | 0.7174 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0075 | 0.0618 | 0.1079 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0136 | 0.2608 | 1 |
Brugia malayi | Hemopexin family protein | 0.0087 | 0.1016 | 0.2947 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.0618 | 0.1537 |
Treponema pallidum | polypeptide deformylase (def) | 0.0232 | 0.5725 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 500 nM | In vitro Angiotensin II receptor antagonism in bovine adrenal cortex tissue. | ChEMBL. | No reference |
IC50 (functional) | = 500 nM | In vitro Angiotensin II receptor antagonism in bovine adrenal cortex tissue. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.